Cipla’s wholly owned subsidiary in Netherlands - Cipla Holding B. V. (Cipla Netherlands), has entered into a joint venture agreement (JVA) with Ahran Tejarat Company to incorporate a joint venture company. As per the joint venture agreement, Cipla Netherlands will hold a 75% stake in a joint venture company in Iran while the JV Partner shall hold the remaining 25% stake.
The total expected investment of Cipla Netherlands in cash in the joint venture company is estimated at being up to a maximum of 16.875 million euro. The joint venture company proposes to undertake manufacturing and marketing of pharmaceutical products in Iran.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: